BEAT · XBRL financial data

HeartBeam financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BEAT's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Research and development	1,623	2,010*	2,428	2,844	2,893	2,886*	3,492	3,326	3,278	3,354*	2,370	2,328
General and administrative	2,114	2,099*	2,356	2,246	2,176	2,058*	2,012	1,711	2,012	1,956*	2,346	2,764
Total operating expenses	3,737	4,109*	4,784	5,090	5,069	4,944*	5,504	5,037	5,290	5,310*	4,716	5,092
Operating income (loss)	(3,737)	(4,109)*	(4,784)	(5,090)	(5,069)	(4,944)*	(5,504)	(5,037)	(5,290)	(5,310)*	(4,716)	(5,092)
Other income (expense)	0	0*	—	—	(6)	(1)*	—	—	—	year only	—	—
Income tax expense (benefit)	0	0*	0	0	0	0*	0	0	0	0*	0	0
Net income (loss)	(3,470)	(3,879)*	(4,606)	(4,956)	(4,979)	(4,907)*	(5,484)	(4,974)	(5,255)	(5,302)*	(4,700)	(5,039)
Earnings per share, basic USD per share	(0.13)	—	(0.17)	(0.19)	(0.19)	(0.18)*	(0.18)	(0.15)	(0.15)	(0.15)*	(0.12)	(0.10)
Earnings per share, diluted USD per share	(0.13)	—	(0.17)	(0.19)	(0.19)	(0.18)*	(0.18)	(0.15)	(0.15)	(0.15)*	(0.12)	(0.10)
Weighted average shares, basic thousands of shares	26,449	—	26,511	26,567	26,752	26,748*	30,379	33,835	34,396	36,159*	40,588	52,775
Weighted average shares, diluted thousands of shares	26,449	—	26,511	26,567	26,752	26,748*	30,379	33,835	34,396	36,159*	40,588	52,775

Fiscal quarters (BEAT's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	19,184	16,189	12,638	9,157	5,768	2,377	4,390	3,256	1,856	4,380	2,039	8,722
Inventory	—	—	—	—	—	0	—	—	—	103	133	110
Prepaid and other current assets	295	636	599	544	376	393	458	308	270	202	263	164
Total current assets	19,479	16,825	13,237	9,701	6,144	2,770	8,608	5,361	2,126	4,685	2,435	8,996
Property and equipment, net	144	256	344	370	457	450	443	564	694	1,102	1,438	1,584
Total assets	19,648	17,131	13,635	10,126	6,657	3,276	9,107	5,981	2,876	5,843	3,929	10,637
Accounts payable	—	556	—	—	—	531	523	814	1,021	1,053	747	608
Accrued liabilities	—	638	—	—	—	1,091	1,055	985	1,449	2,187	2,547	1,852
Total current liabilities	—	1,194	—	1,420	1,856	1,622	1,578	1,799	2,470	3,240	3,294	2,460
Total liabilities	1,019	1,194	1,097	1,420	1,856	1,622	1,578	1,799	2,470	3,240	3,294	2,460
Accumulated deficit	(32,946)	(36,825)	(41,431)	(46,387)	(51,366)	(56,273)	(61,757)	(66,731)	(71,986)	(77,288)	(81,988)	(87,027)
Total stockholders' equity	18,629	15,937	12,538	8,706	4,801	1,654	7,529	4,182	406	2,603	635	8,177
Total liabilities and equity	19,648	17,131	13,635	10,126	6,657	3,276	9,107	5,981	2,876	5,843	3,929	10,637
Common shares outstanding (cover page) thousands of shares	26,329	26,329	26,329	26,562	26,665	33,725	33,807	34,312	34,444	41,088	55,507	56,349

Fiscal quarters (BEAT's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(3,470)	(3,879)*	(4,606)	(4,956)	(4,979)	(4,907)*	(5,484)	(4,974)	(5,255)	(5,302)*	(4,700)	(5,039)
Stock-based compensation	926*	1,187*	1,207	1,040*	1,053*	999*	1,109	1,177*	1,434*	1,427*	1,217	1,701*
Net cash from operating activities	(2,098)*	(2,858)*	(3,463)	(3,550)*	(3,306)*	(4,152)*	(4,477)	(3,445)*	(3,160)*	(2,906)*	(3,610)	(3,342)*
Purchases of property and equipment	144*	112*	88	10*	103*	0*	0	102*	82*	416*	246	249*
Net cash from investing activities	3,795*	(112)*	(88)	(10)*	(103)*	0*	(3,760)	1,861*	1,715*	(416)*	(246)	(249)*
Proceeds from issuing common stock	0*	0*	0	76*	0*	654*	10,250	—	—	—	—	—
Net cash from financing activities	111*	0*	0	84*	21*	761*	10,250	450*	45*	5,846*	1,515	10,275*
Net change in cash	1,808*	(2,970)*	(3,551)	(3,476)*	(3,388)*	(3,391)*	2,013	(1,134)*	(1,400)*	2,524*	(2,341)	6,684*

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
HeartBeam	8,722	not reported	(3,342)*	56.3M	2.6 quarters	Q2 FY26 10-QJun 30, 2026
Modular Medical	3,920	not reported	(5,972)	8.2M	0.7 quarters	Q1 FY27 10-QJun 30, 2026
Vicarious Surgical	1,407	not reported	(6,325)	not reported	0.6 quarters	Q1 FY26 10-QMar 31, 2026
Milestone Scientific	2,067	not reported	(585)*	88.7M	3.5 quarters	Q2 FY26 10-QJun 30, 2026
QT Imaging Holdings	10,924	7,435	(4,837)*	14.6M	2.3 quarters	Q2 FY26 10-QJun 30, 2026
Nuo Therapeutics	449	not reported	(236)*	48.4M	1.9 quarters	Q2 FY26 10-QJun 30, 2026
Alpha Pro Tech	18,901	not reported	2,213*	10.2M	—	Q2 FY26 10-QJun 30, 2026
Cerenome	2,366	411	(7,132)*	7.6M	1.2 quarters	Q2 FY26 10-QJun 30, 2026
Hyperfine	43,458	3,904	(7,268)*	not reported	6.0 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.